Rockefeller Capital Management’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
Other funds holding MRVI
1WCM
Rockefeller Capital Management's MRVI Position: Q3 2026 in Review
Rockefeller Capital Management held its Maravai LifeSciences (MRVI) position steady in Q3 2026 at 3,380 shares worth $25.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3795.
Rockefeller Capital Management first reported a position in MRVI in Q2 2021 and has held it in 10 quarters since. The position peaked at $142K in Q3 2022. 202 funds tracked by Wall St. Rank hold MRVI as of Q3 2026.
- Rockefeller Capital Management held 3,380 shares of Maravai LifeSciences worth $25.9K as of Q3 2026.
- Rockefeller Capital Management left its Maravai LifeSciences share count unchanged in Q3 2026.
- Maravai LifeSciences made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #3795 holding.
- Rockefeller Capital Management first reported a position in Maravai LifeSciences in Q2 2021 and has held it in 10 quarters since.
- Rockefeller Capital Management's Maravai LifeSciences position peaked at $142K in Q3 2022.
- 202 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2026.
Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.